Department for Work and Pensions

home

Site navigation


Care and mobility considerations

Treatment of stage 1, 2 or 3 renal cancer

The majority of people in this group will have had surgery as treatment of their disease. The recovery time form these operations are up to 12 weeks. There are not usually any long term side effects of this type of surgery except those listed under surgery in the treatment section. Chemotherapy is sometimes used in the treatment of transitional cell cancer but not renal cell cancer; it may prolong recovery to 8-9 months or rarely give rise to enduring side effects. Recovery of normal function is expected in the typical case. Radiotherapy is rarely used so the long term side effects of these treatments are unlikely to be a problem for this group.

Stage 4, advanced or recurrent renal cancer after treatment of any stage of the disease

The majority of people are terminally ill; the median survival for this group is 10 months with treatment. The five year survival is 10%.

They may experience any of the following symptoms related to their kidney cancer:

There may be disabling effects from metastatic disease anywhere in the body including:

Note: This guidance does not cover Wilms tumour (a type of kidney cancer) and any such cases in adults must be discussed with Medical Services.

Amended October 2011